Patient preferences for colorectal cancer screening

Journal of Family Practice

Volumn 45, Issue 3, 1997, Pages 211-218

  Leard, Lorriana E ^a,b   Savides, Thomas J ^a,c   Ganiats, Theodore G ^a,b  

^a School of Medicine ^*

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colorectal neoplasma; Patient acceptance of health care; Patient preferences (Non MeSH); Practice guidelines; Preventive health services

Indexed keywords

ADULT; AGED; ARTICLE; BARIUM ENEMA; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; DECISION MAKING; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PATIENT ATTITUDE; SIGMOIDOSCOPY;

AGED; BARIUM; CALIFORNIA; COLONOSCOPY; COLORECTAL NEOPLASMS; ENEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PARTICIPATION; QUESTIONNAIRES; SIGMOIDOSCOPY;

EID: 0030759883     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. American Cancer Society. Cancer statistics. CA Cancer J Clin 1995; 45:8-30.
2. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schulman LM. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 329:1365-71.
3. Atkin WS, Cuzick J, Northover JM, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993; 341:736-40.
4. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326:653-7.
5. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84:1572-5.
6. American Cancer Society. Summary of current guidelines for the cancer related checkup: recommendations. New York, NY: American Cancer Society, 1989.
7. American College of Physicians. Clinical efficacy assessment project. Screening for colorectal cancer. Philadelphia, Pa: American College of Physicians, 1990.
8. US Preventive Services Task Force. Guide to clinical preventive services. Baltimore, Md: Williams & Wilkins, 1995.
9. Eddy DM. Comparing benefits and harms: the balance sheet. JAMA 1990; 263:2493-505.
10. Eddy DM. A manual for assessing health practices and designing practice policies. The explicit approach. Philadelphia, Pa: American College of Physicians, 1992.
11. McConnell JD, Barry MJ, Bruskewitz RC, et al. Benign prostatic hyperplasia: diagnosis and treatment. Quick reference guide for clinicians. Agency for Health Care Policy and Research, 1994. AHCPR publication No. 94-0583.
12. Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990; 13:373-84.
13. Eddy DM. Clinical decision making: from theory to practice. Designing a practice policy. Standard, guidelines, and options. JAMA 1990; 263:3077.
14. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997; 12:594-642.
15. Office of Technology Assessment. Cost-effectiveness of colorectal cancer screening in average-risk adults. Washington, DC: Government Printing Office, 1995. Publication No. OTA-BP-H-146.
16. Bond JH. Polyp guideline: diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps. Ann Intern Med 1993; 119:836-43.
17. McCallum RW, Meyer CT, Marignani P, Cane E, Contino C. Flexible sigmoidoscopy: diagnostic yield in 1015 patients. Am J Gastroenterol 1984; 79:433-7.
18. Gelfand DW. Complications of gastrointestinal radiologic procedures: complications of routine fluoroscopic studies. Gastrointestl Radiol 1980; 5:293-315.
19. Waye JD, Lewis BS, Yessayan S. Colonoscopy: a prospective report of complications. J Clin Gastroenterol 1992; 15:347-51.
20. Kewenter J, Björk S, Haglind E, Smith L, Svanvik J. Screening and rescreening for colorectal cancer. a controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 1988; 62:645-51.
21. Kronborg O, Fenger C, Olsen J, Bech K, Sodergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol 1989; 24:599-606.
22. Hardcastle JD, Thomas WM, Chamerlain J, Pye G, Sheffield J, James PD. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet 1989; 1:1160-4.
23. Winawer SJ, Zauber AG, Gerdes H, Hornsby-Lewis L, O'Brien MJ, Waye J. Reduction in colorectal cancer incidence following colonoscopic polypectomy: Report from the National Polyp Study (NPS). Gastroenterology 1991; 100:A410.
24. Lieberman D. Screening/early detection model for colorectal cancer. Why screen? Cancer. 1994; 74(7 suppl):2023-7.
25. Ransohoff DF. The case for colorectal cancer screening. Hosp Pract 1994; 29(8):25-32.
26. Wherry DC. Screening for colorectal neoplasia in asymptomatic patients using flexible fiberoptic sigmoidoscopy. Dis Colon Rectum 1981; 24:521-2.
27. Marks G, Boggs HW, Castro AF, Gathright JB, Ray JE, Salvati E. Sigmoidoscopic examinations with rigid and flexible fiberoptic sigmoidoscopes in the surgeon's office: a comparative prospective study of effectiveness in 1,012 cases. Dis Colon Rectum 1979; 22:162-8.
28. Lipshutz GR, Katon RM, McCool M, Mayer B, Smith FW, Duffy T. Flexible sigmoidoscopy as a screening procedure for neoplasia of the colon. Surg Gynecol Obstet 1979; 148(1):19-22.
29. Shida H, Yamamoto T. Fiberoptic sigmoidoscopy as the first screening procedure for colorectal neoplasms in an asymptomatic population. Dis Colon Rectum 1989; 32:404-8.
30. Arras JD, Steinbock B, ed. Ethical issues in modern medicine. 4th ed. Mountain View, Calif: Mayfield Publishing Co, 1995.
31. Hlatky MA. Patient preferences and clinical guidelines. JAMA 1995; 273:1219-20.